NPI: 1942247291 · SAN PEDRO, CA 90732 · General Acute Care Hospital · NPI assigned 06/02/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 06/02/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 81,834 | $2.42M |
| 2019 | 68,547 | $2.83M |
| 2020 | 54,167 | $2.11M |
| 2021 | 66,731 | $2.86M |
| 2022 | 71,214 | $3.88M |
| 2023 | 83,952 | $4.93M |
| 2024 | 82,317 | $5.23M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 75,212 | 66,071 | $9.58M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,415 | 2,350 | $1.19M |
| 70450 | Computed tomography, head or brain; without contrast material | 3,668 | 3,585 | $1.01M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,750 | 1,717 | $664K |
| 80053 | Comprehensive metabolic panel | 15,019 | 14,070 | $654K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,193 | 14,912 | $639K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14,966 | 13,965 | $599K |
| 96375 | Therapeutic injection; each additional sequential IV push | 12,962 | 11,592 | $530K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 28,367 | 25,516 | $518K |
| 71045 | Radiologic examination, chest; single view | 9,106 | 8,684 | $478K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12,960 | 12,149 | $464K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,957 | 11,941 | $453K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,538 | 3,930 | $413K |
| 71046 | Radiologic examination, chest; 2 views | 7,847 | 7,631 | $381K |
| 99199 | Unlisted special service, procedure or report | 6,104 | 5,439 | $349K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,698 | 1,574 | $329K |
| Z7502 | 8,874 | 8,697 | $320K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,878 | 7,152 | $309K |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,095 | 8,288 | $259K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,458 | 7,629 | $242K |
| 81001 | 23,464 | 21,842 | $242K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,907 | 2,650 | $235K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,062 | 3,683 | $233K |
| 83690 | 12,069 | 11,144 | $201K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,124 | 2,065 | $191K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,344 | 3,167 | $165K |
| 84484 | 9,194 | 7,560 | $152K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,932 | 4,748 | $136K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,649 | 2,426 | $132K |
| 80076 | 5,536 | 5,253 | $132K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,912 | 2,827 | $126K |
| 87040 | 3,282 | 1,697 | $123K | |
| 76830 | Ultrasound, transvaginal | 1,508 | 1,467 | $119K |
| J7030 | Infusion, normal saline solution , 1000 cc | 9,191 | 8,087 | $114K |
| 0250 | 16,574 | 11,111 | $107K | |
| 93975 | 650 | 635 | $88K | |
| 96376 | 2,424 | 2,069 | $86K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,342 | 2,274 | $85K |
| 83880 | 4,644 | 4,425 | $78K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 943 | 834 | $78K |
| 83605 | 2,495 | 2,145 | $77K | |
| 76801 | 1,044 | 921 | $77K | |
| J3490 | Unclassified drugs | 11,944 | 10,004 | $76K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 10,306 | 9,130 | $73K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 721 | 708 | $72K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,976 | 9,326 | $68K |
| 93971 | 708 | 693 | $67K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,417 | 5,358 | $67K |
| 73562 | 1,505 | 1,387 | $66K | |
| 85610 | 4,912 | 4,690 | $59K | |
| 73630 | 1,579 | 1,508 | $59K | |
| 84702 | 1,368 | 1,177 | $59K | |
| 73610 | 1,535 | 1,483 | $58K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 96 | 96 | $54K |
| 87186 | 1,395 | 1,356 | $52K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 134 | 131 | $45K |
| 73130 | 1,088 | 1,037 | $42K | |
| 90715 | 1,263 | 1,253 | $41K | |
| 73030 | 791 | 758 | $36K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,636 | 557 | $31K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 134 | 132 | $31K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,839 | 3,731 | $29K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,407 | 3,259 | $29K |
| 85730 | 2,003 | 1,949 | $28K | |
| 87807 | 1,275 | 1,256 | $28K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,562 | 613 | $27K |
| 81003 | 3,760 | 3,663 | $26K | |
| 87077 | 1,234 | 1,210 | $25K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,337 | 2,289 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,336 | 2,281 | $23K |
| 81025 | 2,358 | 2,216 | $22K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 873 | 864 | $22K |
| 80143 | 922 | 880 | $21K | |
| J2060 | Injection, lorazepam, 2 mg | 2,201 | 1,909 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,518 | 1,485 | $20K |
| 86900 | 1,957 | 1,898 | $20K | |
| 80179 | 893 | 858 | $20K | |
| 87210 | 1,009 | 988 | $20K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,576 | 2,353 | $19K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 724 | 229 | $18K |
| 70498 | 57 | 57 | $18K | |
| 86901 | 1,971 | 1,899 | $18K | |
| 70496 | 55 | 55 | $17K | |
| 0270 | 9,117 | 6,585 | $17K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,260 | 2,169 | $16K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 517 | 233 | $16K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,335 | 2,178 | $15K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 204 | 187 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 745 | 733 | $14K |
| 86850 | 818 | 793 | $14K | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,135 | 962 | $13K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 406 | 383 | $11K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 29 | 29 | $11K |
| 72100 | 151 | 151 | $10K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 136 | 133 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,309 | 1,297 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 228 | 219 | $8K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,375 | 1,321 | $8K |
| 0762 | 78 | 42 | $8K | |
| 87081 | 740 | 729 | $8K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 901 | 733 | $8K |
| 0761 | 264 | 230 | $8K | |
| 73110 | 243 | 234 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 365 | 357 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,155 | 1,120 | $7K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 567 | 498 | $7K |
| 83735 | 517 | 474 | $7K | |
| S9484 | Crisis intervention mental health services, per hour | 46 | 31 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 74 | 74 | $6K |
| 0350 | 379 | 373 | $6K | |
| J1815 | Injection, insulin, per 5 units | 180 | 160 | $4K |
| 84703 | 181 | 176 | $4K | |
| 76770 | 38 | 38 | $3K | |
| 70486 | 15 | 15 | $3K | |
| 73502 | 56 | 53 | $3K | |
| 96367 | 68 | 68 | $2K | |
| 0324 | 81 | 81 | $2K | |
| 85379 | 268 | 264 | $2K | |
| 93017 | 29 | 29 | $2K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | 27 | $2K |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,655 | 1,433 | $2K |
| 82550 | 113 | 105 | $2K | |
| 93970 | 12 | 12 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 155 | 148 | $2K |
| Z7610 | 355 | 290 | $2K | |
| 29125 | 104 | 103 | $2K | |
| Z9725 | 40 | 40 | $2K | |
| 85027 | 163 | 152 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 38 | 38 | $2K |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 51 | 44 | $2K |
| 71101 | 14 | 14 | $2K | |
| 73140 | 59 | 59 | $1K | |
| 0351 | 229 | 223 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | 27 | 27 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 119 | 109 | $1K |
| 36415 | Collection of venous blood by venipuncture | 243 | 182 | $1K |
| 76870 | 13 | 13 | $1K | |
| 87088 | 198 | 188 | $1K | |
| 73590 | 27 | 25 | $1K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 14 | 13 | $972.05 |
| 97116 | 65 | 40 | $971.80 | |
| 87205 | 28 | 27 | $880.47 | |
| 84100 | 63 | 61 | $850.84 | |
| 0258 | 44 | 37 | $843.36 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 178 | 147 | $638.53 |
| 82248 | 53 | 53 | $620.34 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 25 | 25 | $608.05 |
| 0710 | 130 | 116 | $566.36 | |
| 73080 | 15 | 15 | $437.34 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 63 | 53 | $433.57 |
| 81002 | 253 | 187 | $428.85 | |
| 73090 | 13 | 12 | $399.34 | |
| 0636 | 1,165 | 839 | $345.74 | |
| J1644 | Injection, heparin sodium, per 1000 units | 29 | 12 | $297.70 |
| 82077 | 16 | 15 | $271.17 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 25 | 24 | $265.70 |
| A4217 | Sterile water/saline, 500 ml | 28 | 24 | $246.63 |
| J2704 | Injection, propofol, 10 mg | 13 | 13 | $234.67 |
| 82010 | 15 | 12 | $220.99 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 30 | 27 | $215.10 |
| 87070 | 12 | 12 | $196.89 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 437 | 415 | $196.56 |
| 0301 | 30 | 24 | $161.01 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 13 | 13 | $132.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 28 | 25 | $130.14 |
| 87420 | 12 | 12 | $128.94 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 149 | 146 | $107.20 |
| 86592 | 13 | 13 | $104.26 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 13 | 13 | $93.84 |
| J1940 | Injection, furosemide, up to 20 mg | 14 | 12 | $87.79 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 32 | 31 | $60.07 |
| 0760 | 22 | 22 | $40.54 | |
| 0637 | 42 | 34 | $20.31 | |
| 29130 | 14 | 13 | $6.12 | |
| J7510 | Prednisolone oral, per 5 mg | 14 | 14 | $2.51 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 206 | 171 | $0.00 |
| A9270 | Non-covered item or service | 32 | 12 | $0.00 |
| 0305 | 14 | 14 | $0.00 | |
| 0300 | 14 | 14 | $0.00 |